Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-191.61%
operating margin TTM
-1231.96%
revenue TTM
248.57 Thousand
revenue per share TTM
0.03$
valuation ratios | |
|---|---|
| pe ratio | -6.90 |
| peg ratio | -0.14 |
| price to book ratio | -16.76 |
| price to sales ratio | 13.71 |
| enterprise value multiple | -1.54 |
| price fair value | -16.76 |
profitability ratios | |
|---|---|
| gross profit margin | 97.57% |
| operating profit margin | -1231.96% |
| pretax profit margin | -191.61% |
| net profit margin | -191.61% |
| return on assets | -19.96% |
| return on equity | 97.03% |
| return on capital employed | -472.7% |
liquidity ratio | |
|---|---|
| current ratio | 1.14 |
| quick ratio | 1.14 |
| cash ratio | 0.85 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 100.67 |
| days of payables outstanding | 8,365.05 |
| cash conversion cycle | -8,264.38 |
| receivables turnover | 3.63 |
| payables turnover | 0.04 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.08 |
| debt equity ratio | -0.95 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -17.36 |
| interest coverage | -3,020.21 |
| cash flow to debt ratio | -19.76 |
cash flow ratios | |
|---|---|
| free cash flow per share | -3.29 |
| cash per share | 1.32 |
| operating cash flow per share | -3.25 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -19.76 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -81.67 |
Frequently Asked Questions
When was the last time Daré Bioscience, Inc. (NASDAQ:DARE) reported earnings?
Daré Bioscience, Inc. (DARE) published its most recent earnings results on 14-11-2024.
What is Daré Bioscience, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Daré Bioscience, Inc. (NASDAQ:DARE)'s trailing twelve months ROE is 97.03%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Daré Bioscience, Inc. (DARE) currently has a ROA of -19.96%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did DARE's net profit margin stand at?
DARE reported a profit margin of -191.61% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is DARE's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.14 in the most recent quarter. The quick ratio stood at 1.14, with a Debt/Eq ratio of -0.95.